期刊文献+

多模态MRI在高级别脑胶质瘤放疗中的应用 被引量:22

The application of multimodal MRI in radiotherapy for patients with high-grade glioma
原文传递
导出
摘要 放疗是高级别脑胶质瘤治疗的重要手段之一;目前,对于利用定位CT和常规MRI图像进行靶区勾画的范围仍然没有统一标准随着影像学技术的不断发展,研究者们发现利用多模态MRI包括氢质子磁共振波谱分析(1H-MRS).BOLD-fMRI (血氧水平依赖性功能磁共振)、弥散加权成像(DWI)、弥散张量成像(DTI)等可更有效地评估肿瘤的浸润范围及定位周围重要组织,从而作为一种补充手段应用于靶区勾画和保护危及器官之中:此外?多模态MRI对评估放疗疗效、探测放射损伤及鉴别真假性进展也有一定作用:文章就多模态MR1在高级别脑胶质瘤术后放疗中应用作一综述. Radiotherapy is one of the most important treatments of high-grade gliomas ( HGG). Currently, there has been no consensus on the standards for the delineation of the gross tumor volume ( GTV) based on the simulated computed tomography ( CT) scanning and conventional nuignetic resonance imaging (MRI).As the radiological technology advances, researchers have found that the application of multimodal MRI including 1 H magnetic resonance spectroscopy ( 1 H-MRS), blood oxygenation level dependent functional MRI (BOLD-fMRl), diffusion-weighted MRI ( DWI) and diffusion tensor imaging ( DTI) can evaluate the range of HGG invasion and locate the surrounding vital tissues, thereby serving as a supplement for the delineation of target volume and protection of orgiins at risk. Moreover, multimodal MRI can be utilized to evaluate the clinical efficacy of radiotherapy, detect the radiation-induced injury and differentiate the progressive disease from pseudoprogression, hi this article, the application of niultiniodal MRI in the postoperative radiotherapy for patients with high-grade glioma was reviewed.
作者 查昳琳 徐晓婷 Zha Yilin;Xu Xiaoting(Department of Radiation Oncology. First Affiliated Hospital of Soochoiv Unirersity, Suzhou 215000, China)
出处 《中华放射肿瘤学杂志》 CSCD 北大核心 2019年第3期226-229,共4页 Chinese Journal of Radiation Oncology
基金 苏州市科技发展计划(SYS2018028).
关键词 高级别脑胶质瘤/放射疗法 多模态核磁共振成像 High-gnide glioma/radiothenipy Multimodal magnetic resonance imaging
  • 相关文献

参考文献6

二级参考文献47

  • 1张竞文,伍建林,苗延巍,张清,宋清伟.磁共振弥散加权成像对脑肿瘤瘤周水肿的临床应用[J].中国医学影像技术,2005,21(12):1810-1814. 被引量:18
  • 2Calli C, Kitis O, Yunten N, et al. Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors[ J ]. Eur J Radiol,2006,58(3) : 394.
  • 3Stadlbaner A, Ganslandt O, Buslei R, et al. Gliomas: histopathologic evaluation of changes in directionality and magnitude of water diffusion at diffusion-tensor MR imaging[ J ]. Radiology, 2006,240(3) : 803.
  • 4van Westen D, Latt J, Englund E, et al.Tumor extension in high-grade gliomas assessed with diffusion magnetic resonance imaging: values and lesion-to-brain ratios of apparent diffusion coefficient and fractional anisotropy[J]. Acta Radiol,2006,47(3) : 311.
  • 5Tozer D J, Jager H R, Danchaivijitr N, et al. Apparent diffusion coefficient histograms may predict low-grade glima subtype[J]. NMR Biomed, 2007, 20( 1 ) :49.
  • 6Goebell E, Paustenbach S, Vaeterlein O, et al. Low-grade anaplastic gliomas: differences in architecture evaluated with diffusion-teusor MR imaging[J]. Radiology,2006,239( 1 ) : 217.
  • 7Hakyemez B, Yildirim N, Gokalp G, et al.The contribution of diffusion weighted MR imaging to distinguishing typical from atypical meningimas[J]. Neuroradiology, 2006,48 (8) : 513.
  • 8Ellingson BM, Cloughesy TF, Lai A. Graded functional diffusion map-defined characteristics of apparent diffusion coeffi cients predict overall survivalin recurrent glioblastoma treated with hevacizumab [J]. Neuro Oncol, 2011, 13(10): 1151-1161.
  • 9Bernen HJ, Rijken PF, Peters H, et al. Hypoxia in a human intracerebral glioma model [J]. J Neurosurg, 2000, 93: 449- 454.
  • 10Yamasaki F, Kurisu K, Aoki T, et al. Advantages of high h value diffusion weighted imaging to diagnose pseudo-respon ses in patients with recurrent glioma after bevacizumah treal ment [J]. EurJ Radiol, 2(!12, 81(10): 2805-2810.

共引文献79

同被引文献225

引证文献22

二级引证文献92

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部